BamSEC and AlphaSense Join Forces
Learn More

Skye Bioscience Inc.

NASDAQ: SKYE    
Share price (1/8/25): $3.10    
Market cap (1/8/25): $94.0 million

Material Contracts Filter

EX-10.1
from 10-Q 24 pages Skye Bioscience, Inc. Amended and Restated Omnibus Incentive Plan
12/34/56
EX-10.1
from 8-K 13 pages [***] Certain Information in This Document Has Been Excluded Pursuant to Regulation S-K, Item 601(b)(10). Such Excluded Information Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Executive Employment Agreement
12/34/56
EX-10.3
from 10-Q 10 pages Skye Bioscience, Inc. 2024 Inducement Equity Incentive Plan Restricted Stock Unit Agreement
12/34/56
EX-10.2
from 10-Q 5 pages Notice of Grant of Non-Qualified Stock Option Award – For US Optionees Skye Bioscience, Inc. 2024 Inducement Equity Incentive Plan
12/34/56
EX-10.1
from 10-Q 16 pages Skye Bioscience, Inc. 2024 Inducement Equity Incentive Plan
12/34/56
EX-10.1
from 10-Q 35 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 8-K 16 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 28 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 8-K 16 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 43 pages Material contract
12/34/56
EX-10.2
from 8-K 12 pages Offer to Sell Unit 104 – 9295 198th Street Langley, Bc
12/34/56
EX-10.1
from 8-K 52 pages Article 1 Definitions
12/34/56
EX-10.5
from 10-Q 5 pages Lock-Up Agreement [●], 2023
12/34/56
EX-10.1
from 8-K 3 pages Amendment No. 1 to the Skye Bioscience, Inc. Amended and Restated 2014 Omnibus Incentive Plan
12/34/56
EX-10.4
from 8-K 13 pages Indemnification Agreement
12/34/56
EX-10.3
from 8-K 12 pages Skye Bioscience, Inc. Secured Note and Warrant Purchase Agreement
12/34/56
EX-10.2
from 8-K 23 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 41 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 10-Q 58 pages Office Lease
12/34/56
EX-10.5
from 10-Q 2 pages Amendment to Executive Employment Agreement
12/34/56